Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CERILLIANT™ Rufinamide Solution, 1.0 mg/mL in Acetonitrile:Water (9:1), Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco R0231ML
Description
An antiepileptic drug and anticonvulsant, Rufinamide is approved for the treatment of partial seizures associated with Lennox-Gastaut syndrome in adults and children 4 years and older. Rufinamide is marketed as Banzel™ in the US and Inovelon™ in the EU.
Specifications
| 75-05-8 , 106308-44-5 | |
| UN 1648 3 / PGII | |
| 238.19 | |
| 1 mL |
| C10H8F2N4O | |
| 1.0 mg/mL in acetonitrile:water (9:1) | |
| Ampule | |
| 2°C (35.6°F) - closed cup |
Safety and Handling
H332-H319
Recommended Storage : -20°C
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
CERILLIANT is a registered trademark of Cerilliant Corporation